Serelaxin: a potential new drug for the treatment of acute heart failure
Author:
Affiliation:
1. University of California San Francisco, Department of Medicine, San Francisco, CA, USA
2. San Francisco Veterans Affairs Medical Center, Section of Cardiology, 4150 Clement Street, San Francisco, CA 94131, USA ;
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1517/13543784.2014.924504
Reference65 articles.
1. Heart Disease and Stroke Statistics—2014 Update
2. 2013 ACCF/AHA Guideline for the Management of Heart Failure
3. Treatment of Acutely Decompensated Heart Failure
4. Acute Heart Failure Syndromes
5. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Relaxin and the Cardiovascular System: from Basic Science to Clinical Practice;Current Molecular Medicine;2020-02-10
2. Heart Disease and Relaxin: New Actions for an Old Hormone;Trends in Endocrinology & Metabolism;2018-05
3. Current and emerging pharmacologic options for the management of patients with chronic and acute decompensated heart failure;Expert Review of Clinical Pharmacology;2017-03-30
4. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism;Cardiovascular Research;2017-01-10
5. Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease;Nature Reviews Drug Discovery;2016-06-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3